Human medicines European public assessment report (EPAR): Cabometyx , cabozantinib, Carcinoma, Renal Cell;Carcinomas, Hepatocellular, Date of authorisation: 09/09/2016, Revision: 18, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness